Producing MSC-derived cell therapies: workflows, technologies, and case studies

I Malaspina, S Mei, T Ting et al

28 March 2025

Expert Roundtable

Early-stage analytical development strategies for cell therapy

Ramon Mendoza, Kyle Carter, Seth Peterson

16 January 2025

Expert Roundtable

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

M Carpenter, L Munsie, K Raineri et al

03 September 2024

Expert Roundtable

Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy

David Rangel, Guangping Gao, Nathalie Clement

09 August 2024

Expert Roundtable

Smooth cell therapy analytical assay translation from analytical development to QC

H H Adams, I Shestopalov, K Yeung et al

28 February 2024

Expert Roundtable

Fast-tracking gene therapy breakthroughs: discussing the critical role of rapid testing

R Legmann, G Thakur, S Levy et al

05 January 2024

Expert Roundtable

Biological & operational considerations for iPSC-derived cell production

A Mogen, A Fernandez-Perez, J Wang et al

20 December 2023

Expert Roundtable

Current issues & future trends in cryopreservation for advanced therapies

Jason Acker, Allison Hubel, Sean Werner

20 December 2023

Expert Roundtable

Cell culture in immune cell therapies: do more with less

Anastasiya Smith, Josh Ludwig, David Hermanson

08 June 2023

Expert Roundtable

Accelerating cancer therapies development: the importance of platform, process, and partnership

William Swaney, John (Yoshi) Shyu, Nikhil Tyagi

22 April 2023

Expert Roundtable

Driving the expansion of mRNA into the therapeutic sphere

Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu

10 April 2023

Expert Roundtable

Diagnostic & therapeutic uses for extracellular vesicles: insights into a rapidly evolving field

S Wild, J Correia, A de Fougerolles et al

30 November 2022

Expert Roundtable

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Rupa Pike, Delara Motlagh, Patrick Hanley

05 October 2022

Expert Roundtable

Strategies for scaling up and out in gene therapy manufacturing: addressing AAV’s growing pains

Christopher Reardon, Phillip Vermilion, John Yoshi Shyu

22 March 2022

Expert Roundtable

A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture

L M Drouin, F Dorange, B Silvey et al

13 December 2021

Expert Roundtable

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Tariq Haq

22 November 2021

Expert Roundtable

Expert Roundtable: overcoming challenges in analytical assays for cellular therapies

Jara Joedicke, Eric Alonzo, Marsilius Mues

14 October 2021

Expert Roundtable

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Sarah Snykers, Andrea Moore, Tony Bou Kheir

26 September 2021

Expert Roundtable

Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture

U Saplakoglu, T Kotanchek, D Marshall et al

14 May 2021

Expert Roundtable

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

John Lunger

23 April 2021

Expert Roundtable

Viral vector production process intensification: analytics, automation, in-line testing and more

09 February 2021

Expert Roundtable